Error message

The page you requested does not exist. For your convenience, a search was performed using the query trials ncrn525 azacitidine bsc v placebo bsc aza mds 003.

Search results

  1. Dr Stephen McLaughlin

    ... Hsp90 directed anti-tumour drugs in development and clinical trials. ...

  2. Dr Simon Pacey

    ... development, my research interests are: Early phase clinical trials (phase I/II) and Urological malignancy (prostate cancers). My projects ... proportion of investigator-led, locally sponsored clinical trials. Examples of open clinical trials include: Do Changes in ctDNA ...

  3. Mr Samuel White

    ... actionable genomic results for patients enrolled on clinical trials and clinical studies led by researchers across the Centre.  CMDL ...

  4. Dr Sujath Abbas

    ... DNA, envisioning its implementation in large scale clinical trials/screening. I have a Masters and a Bachelor’s degree in Biochemistry ...

  5. Professor Tony Kouzarides

    ... MLL-leukaemia. This I-BET compound is currently in clinical trials. Tony is part of the Executive Board of the Cambridge Cancer Centre ...

  6. Professor Vincent Gnanapragasam

    ... and completed numerous investigator led multicentre clinical trials including;  Predict Prostate RCT ,  PRIM biomarker ... studies). In recent years he has developed a new clinical trials programme exploring the concept of therapeutic intervention to slow or ...

  7. Dr Will Ince

    ... All phase industry and investigator initiated clinical trials in renal, prostate and recurrent/metastatic head and neck cancer with ...

  8. Mr Isaac Toleman

    ... to predict patient-responses. My bachelors degree was "BSc Biochemistry with Study in Industry", which I completed in the University ...

  9. Mr Shanlin Tong

    ... raised in Beijing and later residing in Sweden, pursued a BSc and MSc in Biomedicine at Karolinska Institutet before attending medical ...

  10. Dr Trevor Littlewood

    The use of classical, germ-line genetics to define gene function in vertebrates is severely limited by embryonic lethality, developmental compensation and adaptive functional degeneracy, all of which obscure the roles played by genes in adult tissues...

  11. Dr Avgi Andreou

  12. Dr Ali Amin Al Olama

    My research has focused on discovery of genetic risk factors of prostate cancer through genome-wide association studies and fine-mapping. I am a core member of an international consortium PRACTICAL (Prostate Cancer Association Group to Investigate...

  13. Mr Arqum Anwar

    Rotation Project: The project aims to investigate the cellular role(s) of a novel factor expected to be involved in DNA damage response. Specifically, the interactome of the protein will be explored using co-immunoprecipitation followed by mass...

  14. Dr Ashwin Seshia

    One of the research thrusts in my group is the development of microelectromechanical and microfluidics based platforms for early diagnosis. We also research microfabricated biophysical tools to characterise biological systems at the molecular, cellular...

  15. Dr Andreas Bender

    Previously affiliated with the Lead Discovery Informatics (LDI) group of Novartis in Cambridge/MA, I am now developing and applying cheminformatics techniques in the drug discovery field in my group with the University of Cambridge. Our expertise ranges...

  16. Dr Alvis Brazma

    High throughput (microarray, sequencing) data analysis. Data integration. Cell cycle. I am in charge of running and developing the transcriptomics data repository ArrayExpress.

  17. Dr Alejandra Bruna

    We aimed to study the effects of the TGF-beta pathway in breast cancer stem cell (BCSC) regulation. To define a role of the TGF-beta pathway in the regulation of human BCSCs, we have analyzed a panel of breast cancer cell lines that represent the...

  18. Professor Antonis Antoniou

    My main research interest is the development and application of statistical modelling techniques for addressing clinical questions, and the development of risk prediction tools which are used in clinical practice. ...

  19. Dr Catherine Lindon

    My lab studies cell division in human cells, with particular focus on regulation by ubiquitin-mediated proteolysis. We use time-lapse fluorescence imaging of live cells to measure proteolysis of substrates in real time, and to study the role of...

  20. Dr Adeeba Fathima Valiya Thodiyil

    Single cell/Tissue imaging, quantitative microscopy, image analysis 

  21. Dr Claudia Ribeiro de Almeida

    B-lymphocytes are cells of the immune system responsible for the production of antibodies, and do so by employing hazardous mechanisms of somatic DNA mutation and DNA deletion-recombination with remarkable efficiency. Increasing evidence suggests a...

  22. Dr Dhoyazan Azazi

  23. Dr Fazal Hadi

    I am currently a joint postdoc between Prof. Jason Carroll's lab and AstraZeneca working to get further insights into mechanism of action of selective estrogen receptor degraders.

  24. Dr Kyren Lazarus

    My overall career ambition is to develop novel insights into breast cancer pathology to help improve clinical outcomes for sufferers. I will be working with Dr Walid Khaled in order to understand transcriptional regulation of cell fate in mammary...

  25. Dr Raza Ali

    (tbc)

  26. Ms BrandonEa BrandonEa

    Obsługi, zaś nie wiemy kiedy dżdżownica ziemi. Ochudzanie. Owo te negatywne pokazują, że jest umiejętności powszechobecne. Owo te negatywne potrafią spowodować emocjonalnej można podzielić na: Kontremocjonalnej wolno podzielić na: Kontremocja w życiem....

  27. Dr Catherine Green

    I run a small group in the Department of Zoology funded by a Cancer Research UK career development fellowship. We are investigating the mechanisms and control of genome replication, both at genetic and epigenetic levels. It is during replication that...

  28. Dr Daniel Hodson

    Pathogenesis of Germinal Centre Derived B Cell Lymphomas. Many of the commonest human lymphomas (including follicular, diffuse large B cell and Burkitt lymphomas) develop from a specific stage of B lymphocyte differentiation termed the Germinal Centre. ...

  29. Dr Helen Davies

  30. Mr James Watson

  31. Professor James Brenton

    Ovarian cancer has a disproportionately high health care burden because of low cure rates and frequent symptoms caused by recurrent bulky abdominal disease after primary therapy. The fundamental clinical problem remains the acquisition of drug...

  32. Dr Janet Maguire

  33. Professor Sir Shankar Balasubramanian

    We are interested in the chemical biology of nucleic acids and the genome. Our research explores the sequence, structure and function of DNA and RNA. We have been exploring four stranded structures, called G-quadruplexes, that can form from particular G...

Pages